E1: Powerpoints Flashcards
N_M
post-junctional; skeletal neuromuscular junction
N_N (N_2)
Autonomic ganglia, adrenal medulla
M1
sympathetic post-ganglionic; some pre-synaptic, lungs
M2
myocardium, smooth muscle, some pre-synaptic sites, lungs
M3
lungs, urinary bladder
M4, M5
No pharmacologic agents
Predominant tone of the SNS (2 locations/actions)
Arteries: vasoconstriction
Kidney: renin secretion
Predominant tone of PNS (2)
Detrusor muscle (bladder)
Resting state
Spinal efferents of SNS
Thoracic and lumbar
Paravertebral ganglion
Spinal efferents of PNS
Cranial, cervical, sacral (ganglion in organs)
Vagus nerve (cranial nerve X, 75% of all PNS activity)
What agents are not use clinically but block the uptake of choline
Hemicholinium and vesamicol
What disrupts SNAPS to prevent the release of Ach into the synaptic cleft
botulinum toxin derivatives
alpha-1 locations
Alpha-1A locations
arteries smooth muscle
Alpha-1A: prostate, urethra
beta-1
heart muscle
beta-2
lung, heart
beta-3
fat cells, urinary bladder (detrusor)
what is the rate limiting enzyme of the adrenergic nerve terminal and what does it do
tyrosine hydroxylase, converts Tyr to DOPA
How does NE get degraded in the synaptic cleft
by COMT
what influences neurotransmitter release (2)
autoreceptors and heteroreceptors
where are autoreceptors found and what do they do
alpha2, decrease NE release
what are heteroreceptors? what NT do they affect
receptors with the ability to influence neurotransmitter release but have less profound effects than autoreceptors
they act on muscarinic receptors to inhibit NE release and on AT1 to stimulate NE release
Metryrosine-Demser
TH inhibitor (decrease NE synthesis)
Reserpine
VMAT inhibitor (inhibits NE storage)
Bretylium
SNAP inhibitor (inhibit NE release)
Phenylzine-Nardil
MAO inhibitor (increase NE in nerve terminal)
Cocaine
inhibits NET; increase NE in synaptic cleft by inhibiting its reuptake
what type of receptors are at the neuromuscular junction
The ach receptors are only nicotinic (N_M)
phenylephrine is a __________ agonist
alpha-1 agonist